Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sodium oligomannurarate - Shanghai Green Valley Pharmaceutical

Next Previous
Search
Drug Profile

Sodium oligomannurarate - Shanghai Green Valley Pharmaceutical

Alternative Names: GV-971; Hamput Sodium; Mannut Sodium; Nine Phase One; Oligomannate; Sodium oligo-mannurarate

Latest Information Update: 26 Dec 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ocean University of China; Shanghai Green Valley Pharmaceutical; Shanghai Institute of Materia Medica
  • Developer Shanghai Green Valley Pharmaceutical
  • Class Antidementias; Mannans; Nootropics; Oligosaccharides
  • Mechanism of Action Amino acid modulators; Amyloid beta-protein inhibitors; Microbiome modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Alzheimer's disease
  • Preclinical Parkinson's disease

Most Recent Events

  • 26 Dec 2024 No development reported - Phase-III for Alzheimer's disease in USA, Taiwan, Poland, Netherlands, Hong Kong, France, Czech Republic, Australia, Canada (PO) (NCT04520412)
  • 23 Nov 2022 Shanghai Green Valley Pharmaceutical suspends the phase III GREEN MEMORY trial for ALzheimer's Disease in China (PO) due to COVID-19 (NCT04520412)
  • 17 Jan 2022 Preclinical trials in Parkinson's disease in China (PO), before January 2022

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top